FDA 483 - Procter & Gamble Manufactura S. de R.L. de C.V. - June 27, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Procter & Gamble Manufactura S. de R.L. de C.V. in Naucapan, Mexico, an OTC human drug manufacturer, revealed significant deficiencies. The firm failed to thoroughly investigate an empty bottle customer complaint due to inadequate check weigher validation. Additionally, batch production records were deficient, lacking proper data integrity controls and identification of personnel supervising critical steps in electronic spreadsheets used for weight verification.
- Office
- Office of Partnerships
- Person
ID · 71e6f255-8d50-446f-9c48-ff9df5e8a582